UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

BACKGROUND: To discover biomarker panels that could distinguish cancers (BC and RCC) from healthy controls (HCs) and bladder cancers (BC) from renal cell carcinoma (RCC), regardless of whether the patients have haematuria. In addition, we also explored the altered metabolomic pathways of BC and RCC....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Wang, Zhan, Liu, Xiaoyan, Liu, Xiang, Sun, Haidan, Guo, Zhengguang, Zheng, Guoyang, Zhang, Yushi, Sun, Wei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896793/
https://ncbi.nlm.nih.gov/pubmed/31805976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6354-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia